Search

everythinglearnresearchcommunity

for

Search:↓

The user has been on oral finasteride and minoxidil for six months without seeing hair loss stabilization and has started taking dutasteride twice a week. Other users shared their experiences with hair loss treatments, with one suggesting dutasteride might be more effective than finasteride.

People discussed their experiences with 0.5 mg daily oral dutasteride for hair loss, with one person not seeing any improvement after 8 months and experiencing side effects like mild gynecomastia and weak erections. They also mentioned using 2.5 mg of oral minoxidil without positive results.

A user is excited to shave their head for a pilgrimage to Saudi Arabia after seeing hair regrowth from using finasteride, minoxidil, Nizoral, and a derma roller. Others in the conversation offer prayers and discuss the religious aspects of shaving for the pilgrimage.

A user shared their experience with hair loss treatments, including finasteride, minoxidil, and RU58841, which improved their hair from a diffuse NW3 to a solid NW2 - 2.5. They noticed significant changes in how people treated them after regrowing their hair, suggesting that attractiveness can greatly impact social interactions and opportunities.

The user, Salty-Peace-577, shared their 5-month update on using 0.5mg oral finasteride and 2.5mg oral minoxidil for hair loss. They experienced significant hair growth, particularly in their eyebrows, and shared their regimen and tips for hair growth. Some users in the conversation also discussed the side effects they experienced with different dosages of the medications.

User starts final hair loss regimen with various treatments and plans to leave subreddit for mental health. Others believe user's hair is fine and the regimen is unnecessary and potentially harmful.

People making comments on others' hair loss, and the different strategies used to deal with it. Treatments mentioned include finasteride and minoxidil.

A 22-year-old is experiencing a receding hairline and has started using minoxidil and finasteride. They are considering using Jamaican black castor oil and are seeking advice on application and dosage, while also exploring microneedling and scalp massaging for hair regrowth.

Hair loss discussion includes treatments like hinoki tree oil and procyanidin b2. Experiences and effectiveness of these treatments are shared.

Hair loss theory involves 3alpha-hydroxysteroid reductase (3AHD) converting DHT to androstenol. Discussion explores potential treatments and encourages more research.

A user shared their experience with hair loss treatments, including finasteride and minoxidil, which caused side effects and didn't yield satisfactory results. They eventually shaved their head, found it liberating, and encouraged others to embrace baldness.

Progress in hair loss treatments is slow, with current options like Minoxidil and finasteride being the most effective for now. A true cure, possibly involving stem cells or donor multiplication, is still considered far off.

The user experienced hair thinning and used Minoxidil and Finasteride over 20+ years, with periods of stopping and restarting treatment, and eventually had a hair transplant. They are considering restarting Minoxidil and Finasteride and are curious about the effectiveness and potential shedding after resuming the treatment.

A young person regrets not starting hair loss treatments like minoxidil and finasteride earlier, leading to significant balding by age 19. They discuss the importance of early intervention and the impact of societal perceptions on those experiencing hair loss.

Finasteride and minoxidil are effective for hair loss, with many users finding them manageable as part of a daily routine. Costs can be reduced by purchasing generic versions, and while some users express concerns about long-term use, most agree the benefits outweigh the inconvenience.

Finasteride users discuss potential side effects, including Post Finasteride Syndrome (PFS), with varying opinions on its legitimacy and impact. Some users report side effects like changes in semen consistency and reduced pre-ejaculate, while others emphasize the rarity and reversibility of side effects.

A 19-20-year-old has been using 0.5 mg of dutasteride daily for a year to combat hair loss, avoiding minoxidil due to side effects. They plan to continue this regimen and consider a future hair transplant, experiencing no significant side effects from dutasteride.

A user experienced hair shedding after six months of using topical minoxidil and is considering adding finasteride to their routine. Many suggest that minoxidil alone is insufficient for stopping hair loss and recommend combining it with finasteride or dutasteride for better results.

Rejuv-3X, a topical blend with GHK-Cu, AHK-Cu, and JXL-089, is used for hair loss, offering a targeted option without finasteride's side effects. The user plans to combine it with microneedling for enhanced results.

Finasteride and minoxidil are commonly recommended by hair transplant clinics, including those in Turkey, despite some negative perceptions and concerns about side effects. The conversation highlights differing opinions on the effectiveness and safety of these treatments, with some users expressing skepticism about side effects and others emphasizing the importance of these medications for successful hair transplants.

A 52-year-old is switching from finasteride to dutasteride to address crown balding, despite concerns about potential side effects. They have used finasteride for nearly 30 years, had a minor hair transplant, and are considering further treatments if dutasteride doesn't improve their condition.

A 20-year-old user shared impressive hair regrowth results after 2.5 months on 1.2 mg finasteride and 3 mg minoxidil, noting the treatment costs around $30-40 monthly. Users discussed the effectiveness, potential side effects, and personal experiences with these treatments.

A 25-year-old male using 1mg finasteride daily and 5% topical minoxidil twice daily noticed slight hair density improvement on the crown, less shedding, and no serious side effects except occasional mild discomfort. He uses Nizoral shampoo for itching and takes Vitamin D and Magnesium supplements, while maintaining a positive mental outlook and working on improving his sleep schedule.

Dutasteride and finasteride can cause watery ejaculate, which may persist for some users. Zinc supplements or switching to topical treatments are suggested to alleviate this side effect.

Hair loss can be caused by various factors such as stress, thyroid issues, and genetics. Treatments mentioned include dutasteride, DHT blockers, and thyroid medication, though results vary.

The user shared their experience with CB-03-01 (Breezula/Clascoterone) for hair loss, noting reduced shedding and improved hair appearance but experiencing significant sleep disturbances and low energy due to HPA axis suppression. They decided to stop using it due to these side effects and are waiting for GT20029 as an alternative.

DHT is important for sexual function and mood, but finasteride and dutasteride can reduce DHT, causing side effects like reduced libido and erectile dysfunction. These treatments are effective for hair loss, but their impact on DHT leads to debate.

The user is using oral and topical minoxidil, along with dutasteride, ketoconazole shampoo, fish oil, pumpkin seed oil, B complex, and other treatments, seeking better hair regrowth results. They are frustrated with the lack of substantial regrowth despite an aggressive routine and are asking for advice on using both forms of minoxidil.

A user is treating hair loss with 0.5mg Dutasteride three times a week, 5mg oral Minoxidil daily, and topical finasteride and minoxidil, seeing some improvement but insufficient density. They are considering increasing Dutasteride dosage and addressing high estradiol levels, while also trying to quit vaping.

Clascoterone 5% solution shows strong potential for hair growth, offering a new treatment for alopecia with minimal side effects. It blocks androgen receptors locally and may be available by late 2026 or early 2027.